Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0211 per EA under NDC 69097084507. Its NADAC has been published 511 times since Sep 14, 2016.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084507
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090478On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 511 times since Sep 14, 2016, and over the history we have for it it has declined 54.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0470 (Jan 11, 2017) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0313 |
| Average price | $0.0298 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 511 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Cyclobenzaprine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0211 per EA (NDC 69097084507), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 54.1%. It has been tracked across 511 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Sep 14, 2016, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0470 (Jan 11, 2017), with a median of $0.0313 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CYCLOBENZAPRINE 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 69097084507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification